Advent Pharma Ltd. (DSE:ADVENT)
Bangladesh · Delayed Price · Currency is BDT 14.40
+0.20 (1.41%)
At close: Nov 12, 2026
Advent Pharma Financials Overview
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 401.85 | 401.85 | 500.49 | 571.67 | 558.05 | 530.47 |
Revenue Growth | -19.71% | -19.71% | -12.45% | 2.44% | 5.20% | 5.34% |
Gross Profit Gross Profit Growth | 121.68 | 121.68 | 175.63 | 227.9 | 222.91 | 220.16 |
Operating Income Operating Income Growth | 62.56 | 62.56 | 95.58 | 141.65 | 135.36 | 133.38 |
Net Income Net Income Growth | 38.9 | 38.9 | 66.87 | 83.99 | 98.64 | 97.53 |
Earnings Per Share EPS Growth | 0.42 | 0.42 | 0.72 | 0.90 | 1.06 | 1.05 |
EPS Growth | -41.67% | -41.51% | -20.38% | -14.85% | 1.14% | -14.14% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 0.45 | 0.45 | 1.77 | 3.97 | 1.07 | 4.31 |
Total Debt Total Debt Growth | 76.41 | 76.41 | 75.79 | 76.01 | 71.59 | 63.92 |
Net Cash (Debt) Net Cash Growth | -75.97 | -75.97 | -74.03 | -72.04 | -70.52 | -59.61 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.82 | -0.82 | -0.79 | -0.77 | -0.76 | -0.64 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 14.38 | 14.38 | 114.74 | 175.13 | 205.3 | 179.57 |
Capital Expenditures CapEx Growth | -12.22 | -12.22 | -94.18 | -162.06 | -202.73 | -191.13 |
Free Cash Flow Free Cash Flow Growth | 2.16 | 2.16 | 20.56 | 13.08 | 2.56 | -11.56 |
Free Cash Flow Growth | -89.50% | -89.50% | 57.25% | 409.89% | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 30.28% | 30.28% | 35.09% | 39.87% | 39.95% | 41.50% |
Operating Margin | 15.57% | 15.57% | 19.10% | 24.78% | 24.26% | 25.14% |
Pretax Margin | 12.73% | 12.73% | 17.24% | 18.15% | 23.05% | 24.56% |
Profit Margin | 9.68% | 9.68% | 13.36% | 14.69% | 17.68% | 18.39% |
FCF Margin | 0.54% | 0.54% | 4.11% | 2.29% | 0.46% | -2.18% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.050 | - | 0.050 | 0.100 | 0.200 | 0.200 |
Dividend Per Share Growth | -70.00% | - | -50.00% | -50.00% | 0% | 1.99% |
Dividend Yield | 0.35% | - | 0.37% | 0.39% | 0.76% | 0.80% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 34.29 | 38.55 | 18.94 | 28.39 | 24.93 | 23.97 |
P/FCF Ratio | 612.17 | 694.08 | 61.59 | 182.32 | 958.68 | - |
PS Ratio | 3.29 | 3.73 | 2.53 | 4.17 | 4.41 | 4.41 |